Navigation Links
Industry Advisor Joins OrthoAccel Technologies, Inc.
Date:1/25/2010

HOUSTON, Jan. 25 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced this week that it has engaged Waldemar "Val" B. Szwajkowski as an advisor and consultant.  Mr. Szwajkowski's relationship with the Company will be primarily focused on strategic development of key markets, and alignment of its operating plans for growth.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that an orthodontic patient wears in the mouth for 20 minutes daily to accelerate orthodontic tooth movement.  A Phase I clinical trial in 2008 in Houston, Texas demonstrated the safety of the device.  The first case in private practice was initiated in October 2009 in the UK, following EU approval.  

Mr. Szwajkowski's background is particularly relevant to OrthoAccel's development of the AcceleDent brand.  His extensive experience includes international business development, sales and marketing, and general management.  While at 3M Unitek, an orthodontic appliance business, his roles included market leadership in Latin American and Europe from the 1980s into the early 2000s.  Mr. Szwajkowski also oversaw several acquisitions and new business launches prior to retiring as Global Head of 3M Unitek, a role he held from 2001 – 2007.  

Michael Lowe, CEO of OrthoAccel, commented, "We are committed to building the AcceleDent brand around the customer above all else and we believe that Val can provide critical insight to help us guide the development of this new product category.  The management team here is very pleased to have his consultation and involvement in what we are doing."  Mr. Szwajkowski remarked, "I look forward to working with OrthoAccel's strong, talented team in bringing a highly innovative product applying leading edge, clinically proven biomedical bone stimulation techniques into the orthodontic market."

Last month, OrthoAccel hired a Director of Sales in the United Kingdom, which is where efforts will be focused in 2010, as well as in Australia.  Canada is also a planned market for this year, although regulatory clearance is pending.  

OrthoAccel is nearing conclusion of another US clinical trial at the UT Health Science Center in San Antonio with an anticipated completion date in 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology.  The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling.  Importantly, the device works complementary with all existing orthodontic technologies.  AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at www.acceledent.com or requested via info@orthoaccel.com

Media Contact  Michael K. Lowe, CEO, +1 (832) 631-1659

SOURCE OrthoAccel Technologies, Inc.

RELATED LINKS
http://www.acceledent.com

'/>"/>

SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
4. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
5. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
6. Health Insurance Industry Contributions to Politicians Block Regulation, Affordability in Health Care Debate, Says FTCR
7. UNH, state health agency, private industry and NASA to tackle Lyme disease
8. System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs
9. Pro-Consumer Drug Safety Reforms Agreed to in Final FDA Bill; Should End Drug Industry Gaming of Safety System
10. AT&T Offers Network Industry-First RFID Solution for Health Care Organizations
11. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility Centers ... as a Cigna Infertility Center of Excellence. The Cigna Center of Excellence recognizes ... an honor to be designated a Cigna Infertility Center of Excellence," said Fertility ...
(Date:11/30/2016)... , ... November 30, 2016 , ... "I hate when ... arm while brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that ... develop this handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and ...
(Date:11/30/2016)... FL (PRWEB) , ... November 30, 2016 , ... ... disorder and mental health treatment has announced the opening of a new eating ... partial hospitalization and intensive outpatient treatment for adults and adolescents, both males and ...
(Date:11/30/2016)... ... November 30, 2016 , ... In recent policy debates, increasing ... public policymakers and system stakeholders in many states. To help them understand this ... Index for Workers’ Compensation, Eighth Edition (MPI-WC) . , “If you are a ...
(Date:11/30/2016)... ... 30, 2016 , ... The Clinical Data Interchange Standards Consortium ... Guidance goes into effect next month. Sponsors whose studies start after December 17, ... Catalog. The current FDA Data Standards Catalog specifies the use of CDISC standards: ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2, 2016  UCB is pleased to announce that 12 scientific ... 70 th American Epilepsy Society (AES) Annual Meeting, which ... , USA. 1-12 Data being ... of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... the current state of the union of epilepsy care and ...
(Date:12/2/2016)... , December 2, 2016 The iShares ... past losses following Trump,s victory early in November. Less ... fund managers are now predicting an uptick in M&A ... equities to see how they have fared at the ... ), Amicus Therapeutics Inc. (NASDAQ: FOLD ), ...
(Date:11/30/2016)... -- Research and Markets has announced the addition of ... report to their offering. ... Detachable coil embolization is a minimally ... detachable coil embolization treatment of cerebral aneurysms is less invasive and requires ... in the wall of an artery in the brain. This area bulges ...
Breaking Medicine Technology: